Bar Harbor BioTechnology to Launch Diagnostic Division
This new division will create genetic diagnostic tests that determine an individual’s risk of developing a disease.
Read MoreSearch Results for: prostate cancer
MabCure Generates 10 Monoclonal Antibodies Against Prostate Cancer
Posted by Clinical Lab Products | Nov 12, 2010 | Biochemicals & Chemical Reagents, Cancer, Prostate |
Biotechnology company MabCure Inc has generated a panel of 10 novel monoclonal antibodies against prostate cancer.
Read MoreStudy: Prostate Cancer Screening Improves Quality of Life
Posted by Clinical Lab Products | Oct 27, 2010 | Cancer, Miscellaneous |
Men treated for prostate cancer who were diagnosed after the start of routine screening had a significantly reduced risk of the disease spreading to other parts of the body within 10 years of treatment.
Read MoreGE Healthcare to Acquire Clarient Inc
Posted by Clinical Lab Products | Oct 25, 2010 | Cancer, Miscellaneous |
GE Healthcare, a unit of General Electric Company, and Clarient Inc announced have entered into a definitive agreement for GE Healthcare to acquire Clarient.
Read MoreGen-Probe Files US Regulatory Application for PROGENSA PCA3 Assay
Posted by Clinical Lab Products | Sep 23, 2010 | Cancer, Miscellaneous |
Gen-Probe announced that the Company has submitted a Premarket Approval Application (PMA) to the FDA for its PROGENSA PCA3 assay.
Read More